SC
AGN

Scotia Capital’s Allergan Inc AGN Stock Holding History

Scotia Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,634
Closed -$560K – 672
2014
Q4 		$560K Buy
2,634
+250
+10% +$49.7K 0.01% 399
2014
Q3 		$425K Buy
2,384
+68
+3% +$11.3K 0.01% 440
2014
Q2 		$392K Buy
2,316
+670
+41% +$104K 0.01% 453
2014
Q1 		$204K Sell
1,646
-513
-24% -$62.5K ﹤0.01% 526
2013
Q4 		$240K Buy
+2,159
New +$206K 0.01% 480
2013
Q3 		– Sell
-2,934
Closed -$247K – 547
2013
Q2 		$247K Buy
+2,934
New +$304K 0.01% 400

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Scotia Capital's AGN Position: Q1 2015 in Review

Scotia Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,634 shares — an estimated $560K sold.

Scotia Capital first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $560K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Scotia Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Scotia Capital sold 2,634 Allergan Inc shares in Q1 2015, an estimated $560K.
  • Scotia Capital first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Scotia Capital's Allergan Inc position peaked at $560K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Scotia Capital's 13F filing for Q1 2015, filed 15 May 2015.